树突细胞和T细胞的Nanoplex集群介导的协同调节放大了瘤特异性的适应性免疫力
Wei Mao1, Yeonju Park2, Songrae Kim3
1Department of Biomedical Materials Engineering, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea; Institute for Molecular Science and Fusion Technology, Kangwon National University, Chuncheon 24341, Republic of Korea.
Biomaterials
|February 19, 2026
概括
这项研究开发了一种双纳集群,通过刺激抗原呈现细胞和抑制免疫检查点来增强抗瘤免疫力. 这种方法将免疫抑制性瘤微环境转化为有效的癌症免疫治疗的免疫能力状态.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 瘤免疫逃避是癌症治疗中的一个主要挑战,通常是由阻碍T细胞激活的免疫检查点分子引起的.
- 不足够的辅助刺激信号限制了免疫系统建立有效的抗癌反应的能力,导致瘤生长和转移.
研究的目的:
- 开发一种用于癌症免疫治疗的新型双纳诺克集群 (NC) 配方.
- 通过同时刺激共刺激途径和抑制免疫检查点来克服瘤免疫逃避.
主要方法:
- 用CpG ODN 1826 (CpG NP) 制备一个纳米复合体 (NP),以刺激Toll-like受体-9 (TLR-9) 并上调CD80/86共刺激分子.
- 使用CTLA-4 siRNA (siCTLA-4 NP) 开发第二个NP,以抑制T细胞上细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 的表达.
- 通过循环添加反应将NP组装成双纳集群 (NC),优化瘤积累和稳定性的尺寸和灵活性.
主要成果:
- 该NC配方表现出高效的内切割性和显著的瘤抑制功效.
- 活体分析显示,NC治疗将瘤微环境从免疫抑制转变为免疫能力.
- 脊髓细胞检测表明,在NC治疗后,抗瘤免疫反应得到加强.
结论:
- 开发的NC配方有效地将CTLA-4抑制与树突细胞 (DC) 刺激相结合.
- 这种双重作用的方法增强了对瘤的免疫反应,为癌症免疫治疗提供了一个有希望的策略.
- 这些发现为克服瘤免疫逃避和提高癌症治疗结果提供了新的见解.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K


